All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Neural Cell Neoplasm | NCIT_C7060 | |
| Premenopausal | NCIT_C15491 | [Prior to menopause.] |
| Estrogen Receptor Positive | NCIT_C15492 | [An indication that estrogen receptor alpha expression has been detected in a sample.] |
| Estrogen Receptor Status | NCIT_C16150 | [The estrogen receptor level measured in a primary tumor or in metastases. There are essentially two distinct forms of breast cancer, one that tends to have an early onset and is characterized by an ER- status, and one that tends to have a late onset and is characterized by an ER+ status. However, these two variants tend to overlap with respect to age, so it is possible for a young woman to have a "late-onset" form of breast cancer and for an older woman to have an "early-onset" variant of the disease.] |
| Estrogen Receptor Negative | NCIT_C15493 | [The absence of detectable estrogen receptor alpha in a tissue sample.] |
| Fatigue Assessment and Management | NCIT_C15494 | |
| Estrogen Receptor Status Unknown | NCIT_C15495 | [Indicates that the test result for estrogen receptor alpha is unknown or the test has not been performed.] |
| Lymphoproliferative Disorder | NCIT_C9308 | [A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).] |
| Hematopoietic and Lymphoid Cell Neoplasm | NCIT_C27134 | [A neoplasm arising from hematopoietic cells found in the bone marrow, peripheral blood, lymph nodes and spleen (organs of the hematopoietic system). Hematopoietic cell neoplasms can also involve other anatomic sites (e.g. central nervous system, gastrointestinal tract), either by metastasis, direct tumor infiltration, or neoplastic transformation of extranodal lymphoid tissues. The commonest forms are the various types of leukemia, Hodgkin and non-Hodgkin lymphomas, myeloproliferative neoplasms, and myelodysplastic syndromes.] |
| Progesterone Receptor Positive | NCIT_C15496 | [An indication that progesterone receptor (PRG; PR) expression has been detected in a sample.] |
| Progesterone Receptor Status | NCIT_C16149 | [Indicates the progesterone receptor level measured in a primary tumor or in metastases. (>=10 is positive if measured in fmols/mg cytosol protein; Otherwise use institutional standards)] |
| Megakaryocytic Neoplasm | NCIT_C7066 | [A neoplasm affecting cells of the megakaryocytic lineage.] |
| Progesterone Receptor Negative | NCIT_C15497 | [An indication that progesterone receptor (PRG; PR) expression has not been detected in a sample.] |
| Progesterone Receptor Status Unknown | NCIT_C15498 | |
| Prior Oophorectomy | NCIT_C15499 | |
| Retinal Cell Neoplasm | NCIT_C7061 | [A neoplasm arising from the neural retina. This category includes retinoblastoma and retinocytoma.] |
| Neuroepithelial Neoplasm | NCIT_C3787 | [A neoplasm of the nervous system that arises from the neuroepithelial tissues. Representative examples include astrocytic tumors, oligodendroglial tumors, ependymal tumors, and primitive neuroectodermal tumors.] |
| Retinal Neoplasm | NCIT_C4800 | [A benign or malignant neoplasm affecting the retina. Representative examples of benign neoplasms include retinocytoma and hemangioma. Representative examples of malignant neoplasms include retinoblastoma, lymphoma and melanoma.] |
| Neoplasm | NCIT_C3262 | [A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.] |
| Notochordal Tumor | NCIT_C7063 | [A bone tumor arising from the remnants of the fetal notochord. This category includes the chordoma and benign notochordal cell tumor.] |